Clinical benefit in Phase-I trials of novel molecularly...

British Journal of Cancer 2009 / 05 Vol. 100; Iss. 9

Clinical benefit in Phase-I trials of novel molecularly targeted agents: does dose matter?

Postel-Vinay, S, Arkenau, H-T, Olmos, D, Ang, J, Barriuso, J, Ashley, S, Banerji, U, De-Bono, J, Judson, I, Abbruzzese, J L
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
100
Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/sj.bjc.6605030
Date:
May, 2009
File:
PDF, 172 KB
english, 2009
Conversion to is in progress
Conversion to is failed